Detalhes do Documento

Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial


Descrição

Submitted by Biblioteca Suporte PUCRS (biblioteca.suporte@pucrs.br) on 2022-05-17T19:50:34Z No. of bitstreams: 2 Correlation_of_PDL1_Tumor_Expression_and_Treatment_Outcomes_in_Patients_with_Renal_Cell_Carcinoma_Receiving_Sunitinib.pdf: 666416 bytes, checksum: aa67ee507d4344887954cd87956ee5a4 (MD5) Correlation_of_PDL1_Tumor_Expression_and_Treatment_Outcomes_in_Patients_with_Renal_Cell_Carcinoma_Receiving_Sunitinib.pdf: 666416 bytes, checksum: aa67ee507d4344887954cd87956ee5a4 (MD5)

Made available in DSpace on 2022-05-17T19:50:34Z (GMT). No. of bitstreams: 2 Correlation_of_PDL1_Tumor_Expression_and_Treatment_Outcomes_in_Patients_with_Renal_Cell_Carcinoma_Receiving_Sunitinib.pdf: 666416 bytes, checksum: aa67ee507d4344887954cd87956ee5a4 (MD5) Correlation_of_PDL1_Tumor_Expression_and_Treatment_Outcomes_in_Patients_with_Renal_Cell_Carcinoma_Receiving_Sunitinib.pdf: 666416 bytes, checksum: aa67ee507d4344887954cd87956ee5a4 (MD5) Previous issue date: 2015

Tipo de Documento Artigo científico
Idioma Inglês
facebook logo  linkedin logo  twitter logo 
mendeley logo

Documentos Relacionados

Não existem documentos relacionados.